Pfizer Inc. said Thursday the cancer drug Sutent did not meet key goals in two late-stage studies focusing on advanced breast cancer. The drug is already sold as a treatment for advanced kidney cancer and gastrointestinal stromal cancer, which affects the stomach. Both breast cancer studies ...

WASHINGTON (Reuters) - An experimental approach that looks for the DNA leaking out from dead and dying cells may provide a route to a blood test for breast cancer, U.S. researchers reported on Tuesday. An initial study showed the test detected 70 percent of breast cancer cases, and correctly cleared 100 percent of women who did not have breast cancer ...

NEW YORK (Reuters Health) - Diets high in vegetables, fruits and soy might cut the risk of developing breast cancer by 30 percent, new research suggests. In a study, Dr. Lesley M. Butler, of Colorado State University and colleagues, noticed a trend of "decreasing breast cancer risk with increasing intake of a vegetable-fruit-soy dietary pattern" in the 34,000 Chinese women ...